Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00258947|
Recruitment Status : Completed
First Posted : November 28, 2005
Last Update Posted : February 1, 2012
To estimate the smallpox vaccination take rate in healthy young adults not previously vaccinated with a smallpox vaccine.
To describe antibody response to vaccination and evaluate the take for each subject at various timepoints for each batch and pooled batches and to evaluate local signs, symptoms, and overall safety in healthy young adults not previously vaccinated with a smallpox vaccine.
|Condition or disease||Intervention/treatment||Phase|
|Smallpox Poxvirus Infection||Biological: Smallpox vaccine, LISTER strain, from chick embryo cells||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||230 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Take Evaluation and Safety of Smallpox Vaccine (LISTER Strain) in Naïve Healthy Adults.|
|Study Start Date :||September 2005|
|Actual Primary Completion Date :||December 2006|
|Actual Study Completion Date :||January 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00258947
|Study Director:||Medical Director||Sanofi Pasteur Inc|